aspirin and dipyridamole (16714-964)

Drug Facts

Product Profile

Brand Name aspirin and dipyridamole

Generic Name aspirin and dipyridamole

Labeler northstar rx llc

Dosage Form CAPSULE, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

aspirin 25 mg/1, dipyridamole 200 mg/1

Manufacturer

NorthStar Rx LLC

Identifiers & Regulatory

Product NDC 16714-964

Product ID 16714-964_7e2fb079-3302-fd35-dab4-1991e997daec

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA209048

Listing Expiration 2026-12-31

Marketing Start 2019-04-03

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16714964

Hyphenated Format 16714-964

Supplemental Identifiers

RxCUI

259081

UPC

0316714964010

UNII

R16CO5Y76E 64ALC7F90C

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin and dipyridamole (source: ndc)

Generic Name aspirin and dipyridamole (source: ndc)

Application Number ANDA209048 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
200 mg/1

source: ndc

Packaging

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-964-01)

source: ndc

Packages (1)

16714-964-01 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-964-01)

Ingredients (2)

aspirin (25 mg/1) dipyridamole (200 mg/1)

Linked Drug Pages (1)

Aspirin and Dipyridamole ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "7e2fb079-3302-fd35-dab4-1991e997daec", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0316714964010"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["465bbdac-a483-689a-811f-32923ea99fa7"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["NorthStar Rx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-964-01)", "package_ndc": "16714-964-01", "marketing_start_date": "20190403"}], "brand_name": "Aspirin and Dipyridamole", "product_id": "16714-964_7e2fb079-3302-fd35-dab4-1991e997daec", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "16714-964", "generic_name": "Aspirin and Dipyridamole", "labeler_name": "NorthStar Rx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aspirin and Dipyridamole", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA209048", "marketing_category": "ANDA", "marketing_start_date": "20190403", "listing_expiration_date": "20261231"}